The Use of the Quadrivalent Human Papillomavirus Vaccine (Gardasil) as Adjuvant Therapy in the Treatment of Recurrent Respiratory Papilloma
Journal of Voice (2015) Vol. 29, No. 2, pp. 223-229

Objective: To examine the effect of the quadrivalent human papillomavirus vaccine, Gardasil, on the disease course of patients with recurrent respiratory papillomatosis (RRP). A retrospective chart review of patients with RRP was conducted and 20 patients were selected who had ...